NEW YORK (360Dx) – ZenTech said on Wednesday it has inked a strategic agreement to transfer its radioimmunoassay portfolio to Diasource ImmunoAssays, a supplier of manual radioimmunoassay and ELISA kits.

Diasource will also assume production and sales of the ZenTech products. Financial and other terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.